カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗炎症性サイトカインの世界市場見通し2023年-2029年

◆英語タイトル：Anti-Inflammatory Cytokine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5685）

◆商品コード：MMG23JU5685
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anti-Inflammatory Cytokine Market 調査レポートは次の情報を含め、グローバルにおけるの抗炎症性サイトカイン市場規模と予測を収録しています。・世界の抗炎症性サイトカイン市場：売上、2018年-2023年、2024年-2029年
・世界の抗炎症性サイトカイン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗炎症性サイトカイン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口式」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗炎症性サイトカインのグローバル主要企業は、Merck KGaA、 Eli Lilly and Company、 Pfizer Inc.、 Sanofi S.A.、 Novartis AG、 Hoffmann-La Roche Ltd.、 Lonza Group Ltd.、 Thermo Fisher Scientific、 Meridian Bioscience Inc.、 General Electric Company、 Abcam PLC、 GenScript Biotech Corp、 Applied Biological Materials Inc.、 Randox Laboratoriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗炎症性サイトカインのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗炎症性サイトカイン市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗炎症性サイトカイン市場：タイプ別市場シェア、2022年
・経口式、点滴式、その他

世界の抗炎症性サイトカイン市場：用途別、2018年-2023年、2024年-2029年
世界の抗炎症性サイトカイン市場：用途別市場シェア、2022年
・心血管疾患、変形性関節症、その他

世界の抗炎症性サイトカイン市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗炎症性サイトカイン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗炎症性サイトカインのグローバル売上、2018年-2023年
・主要企業における抗炎症性サイトカインのグローバル売上シェア、2022年
・主要企業における抗炎症性サイトカインのグローバル販売量、2018年-2023年
・主要企業における抗炎症性サイトカインのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck KGaA、 Eli Lilly and Company、 Pfizer Inc.、 Sanofi S.A.、 Novartis AG、 Hoffmann-La Roche Ltd.、 Lonza Group Ltd.、 Thermo Fisher Scientific、 Meridian Bioscience Inc.、 General Electric Company、 Abcam PLC、 GenScript Biotech Corp、 Applied Biological Materials Inc.、 Randox Laboratories

*************************************************************

・調査・分析レポートの概要
抗炎症性サイトカイン市場の定義
市場セグメント
世界の抗炎症性サイトカイン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗炎症性サイトカイン市場規模
世界の抗炎症性サイトカイン市場規模：2022年 VS 2029年
世界の抗炎症性サイトカイン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗炎症性サイトカインの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗炎症性サイトカイン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口式、点滴式、その他
抗炎症性サイトカインのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：心血管疾患、変形性関節症、その他
抗炎症性サイトカインの用途別グローバル売上・予測

・地域別市場分析
地域別抗炎症性サイトカイン市場規模 2022年と2029年
地域別抗炎症性サイトカイン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck KGaA、 Eli Lilly and Company、 Pfizer Inc.、 Sanofi S.A.、 Novartis AG、 Hoffmann-La Roche Ltd.、 Lonza Group Ltd.、 Thermo Fisher Scientific、 Meridian Bioscience Inc.、 General Electric Company、 Abcam PLC、 GenScript Biotech Corp、 Applied Biological Materials Inc.、 Randox Laboratories
...

Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer.
This report aims to provide a comprehensive presentation of the global market for Anti-Inflammatory Cytokine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Inflammatory Cytokine. This report contains market size and forecasts of Anti-Inflammatory Cytokine in global, including the following market information:
Global Anti-Inflammatory Cytokine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Inflammatory Cytokine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Inflammatory Cytokine companies in 2022 (%)
The global Anti-Inflammatory Cytokine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Inflammatory Cytokine include Merck KGaA, Eli Lilly and Company, Pfizer Inc., Sanofi S.A., Novartis AG, Hoffmann-La Roche Ltd., Lonza Group Ltd., Thermo Fisher Scientific and Meridian Bioscience Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Inflammatory Cytokine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Inflammatory Cytokine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Inflammatory Cytokine Market Segment Percentages, by Type, 2022 (%)
Oral
Intravenous
Others
Global Anti-Inflammatory Cytokine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Inflammatory Cytokine Market Segment Percentages, by Application, 2022 (%)
Cardiovascular Diseases
Osteoarthritis
Others
Global Anti-Inflammatory Cytokine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Inflammatory Cytokine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Inflammatory Cytokine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Inflammatory Cytokine revenues share in global market, 2022 (%)
Key companies Anti-Inflammatory Cytokine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Inflammatory Cytokine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KGaA
Eli Lilly and Company
Pfizer Inc.
Sanofi S.A.
Novartis AG
Hoffmann-La Roche Ltd.
Lonza Group Ltd.
Thermo Fisher Scientific
Meridian Bioscience Inc.
General Electric Company
Abcam PLC
GenScript Biotech Corp
Applied Biological Materials Inc.
Randox Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Inflammatory Cytokine, market overview.
Chapter 2: Global Anti-Inflammatory Cytokine market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Inflammatory Cytokine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Inflammatory Cytokine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Inflammatory Cytokine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti-Inflammatory Cytokine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Inflammatory Cytokine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Inflammatory Cytokine Overall Market Size
2.1 Global Anti-Inflammatory Cytokine Market Size: 2022 VS 2029
2.2 Global Anti-Inflammatory Cytokine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Inflammatory Cytokine Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Inflammatory Cytokine Players in Global Market
3.2 Top Global Anti-Inflammatory Cytokine Companies Ranked by Revenue
3.3 Global Anti-Inflammatory Cytokine Revenue by Companies
3.4 Global Anti-Inflammatory Cytokine Sales by Companies
3.5 Global Anti-Inflammatory Cytokine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Inflammatory Cytokine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Inflammatory Cytokine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Inflammatory Cytokine Players in Global Market
3.8.1 List of Global Tier 1 Anti-Inflammatory Cytokine Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Inflammatory Cytokine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-Inflammatory Cytokine Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Intravenous
4.1.4 Others
4.2 By Type – Global Anti-Inflammatory Cytokine Revenue & Forecasts
4.2.1 By Type – Global Anti-Inflammatory Cytokine Revenue, 2018-2023
4.2.2 By Type – Global Anti-Inflammatory Cytokine Revenue, 2024-2029
4.2.3 By Type – Global Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
4.3 By Type – Global Anti-Inflammatory Cytokine Sales & Forecasts
4.3.1 By Type – Global Anti-Inflammatory Cytokine Sales, 2018-2023
4.3.2 By Type – Global Anti-Inflammatory Cytokine Sales, 2024-2029
4.3.3 By Type – Global Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
4.4 By Type – Global Anti-Inflammatory Cytokine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-Inflammatory Cytokine Market Size, 2022 & 2029
5.1.2 Cardiovascular Diseases
5.1.3 Osteoarthritis
5.1.4 Others
5.2 By Application – Global Anti-Inflammatory Cytokine Revenue & Forecasts
5.2.1 By Application – Global Anti-Inflammatory Cytokine Revenue, 2018-2023
5.2.2 By Application – Global Anti-Inflammatory Cytokine Revenue, 2024-2029
5.2.3 By Application – Global Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
5.3 By Application – Global Anti-Inflammatory Cytokine Sales & Forecasts
5.3.1 By Application – Global Anti-Inflammatory Cytokine Sales, 2018-2023
5.3.2 By Application – Global Anti-Inflammatory Cytokine Sales, 2024-2029
5.3.3 By Application – Global Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
5.4 By Application – Global Anti-Inflammatory Cytokine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti-Inflammatory Cytokine Market Size, 2022 & 2029
6.2 By Region – Global Anti-Inflammatory Cytokine Revenue & Forecasts
6.2.1 By Region – Global Anti-Inflammatory Cytokine Revenue, 2018-2023
6.2.2 By Region – Global Anti-Inflammatory Cytokine Revenue, 2024-2029
6.2.3 By Region – Global Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
6.3 By Region – Global Anti-Inflammatory Cytokine Sales & Forecasts
6.3.1 By Region – Global Anti-Inflammatory Cytokine Sales, 2018-2023
6.3.2 By Region – Global Anti-Inflammatory Cytokine Sales, 2024-2029
6.3.3 By Region – Global Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti-Inflammatory Cytokine Revenue, 2018-2029
6.4.2 By Country – North America Anti-Inflammatory Cytokine Sales, 2018-2029
6.4.3 US Anti-Inflammatory Cytokine Market Size, 2018-2029
6.4.4 Canada Anti-Inflammatory Cytokine Market Size, 2018-2029
6.4.5 Mexico Anti-Inflammatory Cytokine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti-Inflammatory Cytokine Revenue, 2018-2029
6.5.2 By Country – Europe Anti-Inflammatory Cytokine Sales, 2018-2029
6.5.3 Germany Anti-Inflammatory Cytokine Market Size, 2018-2029
6.5.4 France Anti-Inflammatory Cytokine Market Size, 2018-2029
6.5.5 U.K. Anti-Inflammatory Cytokine Market Size, 2018-2029
6.5.6 Italy Anti-Inflammatory Cytokine Market Size, 2018-2029
6.5.7 Russia Anti-Inflammatory Cytokine Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Inflammatory Cytokine Market Size, 2018-2029
6.5.9 Benelux Anti-Inflammatory Cytokine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti-Inflammatory Cytokine Revenue, 2018-2029
6.6.2 By Region – Asia Anti-Inflammatory Cytokine Sales, 2018-2029
6.6.3 China Anti-Inflammatory Cytokine Market Size, 2018-2029
6.6.4 Japan Anti-Inflammatory Cytokine Market Size, 2018-2029
6.6.5 South Korea Anti-Inflammatory Cytokine Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Inflammatory Cytokine Market Size, 2018-2029
6.6.7 India Anti-Inflammatory Cytokine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti-Inflammatory Cytokine Revenue, 2018-2029
6.7.2 By Country – South America Anti-Inflammatory Cytokine Sales, 2018-2029
6.7.3 Brazil Anti-Inflammatory Cytokine Market Size, 2018-2029
6.7.4 Argentina Anti-Inflammatory Cytokine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti-Inflammatory Cytokine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti-Inflammatory Cytokine Sales, 2018-2029
6.8.3 Turkey Anti-Inflammatory Cytokine Market Size, 2018-2029
6.8.4 Israel Anti-Inflammatory Cytokine Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Inflammatory Cytokine Market Size, 2018-2029
6.8.6 UAE Anti-Inflammatory Cytokine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Company Summary
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Anti-Inflammatory Cytokine Major Product Offerings
7.1.4 Merck KGaA Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.1.5 Merck KGaA Key News & Latest Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Anti-Inflammatory Cytokine Major Product Offerings
7.2.4 Eli Lilly and Company Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.2.5 Eli Lilly and Company Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Anti-Inflammatory Cytokine Major Product Offerings
7.3.4 Pfizer Inc. Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Company Summary
7.4.2 Sanofi S.A. Business Overview
7.4.3 Sanofi S.A. Anti-Inflammatory Cytokine Major Product Offerings
7.4.4 Sanofi S.A. Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi S.A. Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Anti-Inflammatory Cytokine Major Product Offerings
7.5.4 Novartis AG Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Hoffmann-La Roche Ltd.
7.6.1 Hoffmann-La Roche Ltd. Company Summary
7.6.2 Hoffmann-La Roche Ltd. Business Overview
7.6.3 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Major Product Offerings
7.6.4 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.6.5 Hoffmann-La Roche Ltd. Key News & Latest Developments
7.7 Lonza Group Ltd.
7.7.1 Lonza Group Ltd. Company Summary
7.7.2 Lonza Group Ltd. Business Overview
7.7.3 Lonza Group Ltd. Anti-Inflammatory Cytokine Major Product Offerings
7.7.4 Lonza Group Ltd. Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.7.5 Lonza Group Ltd. Key News & Latest Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Company Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Anti-Inflammatory Cytokine Major Product Offerings
7.8.4 Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.8.5 Thermo Fisher Scientific Key News & Latest Developments
7.9 Meridian Bioscience Inc.
7.9.1 Meridian Bioscience Inc. Company Summary
7.9.2 Meridian Bioscience Inc. Business Overview
7.9.3 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Major Product Offerings
7.9.4 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.9.5 Meridian Bioscience Inc. Key News & Latest Developments
7.10 General Electric Company
7.10.1 General Electric Company Company Summary
7.10.2 General Electric Company Business Overview
7.10.3 General Electric Company Anti-Inflammatory Cytokine Major Product Offerings
7.10.4 General Electric Company Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.10.5 General Electric Company Key News & Latest Developments
7.11 Abcam PLC
7.11.1 Abcam PLC Company Summary
7.11.2 Abcam PLC Anti-Inflammatory Cytokine Business Overview
7.11.3 Abcam PLC Anti-Inflammatory Cytokine Major Product Offerings
7.11.4 Abcam PLC Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.11.5 Abcam PLC Key News & Latest Developments
7.12 GenScript Biotech Corp
7.12.1 GenScript Biotech Corp Company Summary
7.12.2 GenScript Biotech Corp Anti-Inflammatory Cytokine Business Overview
7.12.3 GenScript Biotech Corp Anti-Inflammatory Cytokine Major Product Offerings
7.12.4 GenScript Biotech Corp Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.12.5 GenScript Biotech Corp Key News & Latest Developments
7.13 Applied Biological Materials Inc.
7.13.1 Applied Biological Materials Inc. Company Summary
7.13.2 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Business Overview
7.13.3 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Major Product Offerings
7.13.4 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.13.5 Applied Biological Materials Inc. Key News & Latest Developments
7.14 Randox Laboratories
7.14.1 Randox Laboratories Company Summary
7.14.2 Randox Laboratories Business Overview
7.14.3 Randox Laboratories Anti-Inflammatory Cytokine Major Product Offerings
7.14.4 Randox Laboratories Anti-Inflammatory Cytokine Sales and Revenue in Global (2018-2023)
7.14.5 Randox Laboratories Key News & Latest Developments
8 Global Anti-Inflammatory Cytokine Production Capacity, Analysis
8.1 Global Anti-Inflammatory Cytokine Production Capacity, 2018-2029
8.2 Anti-Inflammatory Cytokine Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Inflammatory Cytokine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Inflammatory Cytokine Supply Chain Analysis
10.1 Anti-Inflammatory Cytokine Industry Value Chain
10.2 Anti-Inflammatory Cytokine Upstream Market
10.3 Anti-Inflammatory Cytokine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Inflammatory Cytokine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anti-Inflammatory Cytokine in Global Market
Table 2. Top Anti-Inflammatory Cytokine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Inflammatory Cytokine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Inflammatory Cytokine Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Inflammatory Cytokine Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Inflammatory Cytokine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Inflammatory Cytokine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Anti-Inflammatory Cytokine Product Type
Table 9. List of Global Tier 1 Anti-Inflammatory Cytokine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Inflammatory Cytokine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Inflammatory Cytokine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Inflammatory Cytokine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Inflammatory Cytokine Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Inflammatory Cytokine Sales (K Units), 2024-2029
Table 16. By Application – Global Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Inflammatory Cytokine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Inflammatory Cytokine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Inflammatory Cytokine Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Inflammatory Cytokine Sales (K Units), 2024-2029
Table 21. By Region – Global Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Inflammatory Cytokine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Inflammatory Cytokine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Inflammatory Cytokine Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Inflammatory Cytokine Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Inflammatory Cytokine Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Inflammatory Cytokine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Inflammatory Cytokine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Inflammatory Cytokine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Inflammatory Cytokine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Inflammatory Cytokine Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Inflammatory Cytokine Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Inflammatory Cytokine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Inflammatory Cytokine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Inflammatory Cytokine Sales, (K Units), 2024-2029
Table 46. Merck KGaA Company Summary
Table 47. Merck KGaA Anti-Inflammatory Cytokine Product Offerings
Table 48. Merck KGaA Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck KGaA Key News & Latest Developments
Table 50. Eli Lilly and Company Company Summary
Table 51. Eli Lilly and Company Anti-Inflammatory Cytokine Product Offerings
Table 52. Eli Lilly and Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Eli Lilly and Company Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Anti-Inflammatory Cytokine Product Offerings
Table 56. Pfizer Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. Sanofi S.A. Company Summary
Table 59. Sanofi S.A. Anti-Inflammatory Cytokine Product Offerings
Table 60. Sanofi S.A. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sanofi S.A. Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Anti-Inflammatory Cytokine Product Offerings
Table 64. Novartis AG Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Hoffmann-La Roche Ltd. Company Summary
Table 67. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Product Offerings
Table 68. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 70. Lonza Group Ltd. Company Summary
Table 71. Lonza Group Ltd. Anti-Inflammatory Cytokine Product Offerings
Table 72. Lonza Group Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Lonza Group Ltd. Key News & Latest Developments
Table 74. Thermo Fisher Scientific Company Summary
Table 75. Thermo Fisher Scientific Anti-Inflammatory Cytokine Product Offerings
Table 76. Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Thermo Fisher Scientific Key News & Latest Developments
Table 78. Meridian Bioscience Inc. Company Summary
Table 79. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Product Offerings
Table 80. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Meridian Bioscience Inc. Key News & Latest Developments
Table 82. General Electric Company Company Summary
Table 83. General Electric Company Anti-Inflammatory Cytokine Product Offerings
Table 84. General Electric Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. General Electric Company Key News & Latest Developments
Table 86. Abcam PLC Company Summary
Table 87. Abcam PLC Anti-Inflammatory Cytokine Product Offerings
Table 88. Abcam PLC Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Abcam PLC Key News & Latest Developments
Table 90. GenScript Biotech Corp Company Summary
Table 91. GenScript Biotech Corp Anti-Inflammatory Cytokine Product Offerings
Table 92. GenScript Biotech Corp Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. GenScript Biotech Corp Key News & Latest Developments
Table 94. Applied Biological Materials Inc. Company Summary
Table 95. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Product Offerings
Table 96. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Applied Biological Materials Inc. Key News & Latest Developments
Table 98. Randox Laboratories Company Summary
Table 99. Randox Laboratories Anti-Inflammatory Cytokine Product Offerings
Table 100. Randox Laboratories Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Randox Laboratories Key News & Latest Developments
Table 102. Anti-Inflammatory Cytokine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Anti-Inflammatory Cytokine Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Anti-Inflammatory Cytokine Production by Region, 2018-2023 (K Units)
Table 105. Global Anti-Inflammatory Cytokine Production by Region, 2024-2029 (K Units)
Table 106. Anti-Inflammatory Cytokine Market Opportunities & Trends in Global Market
Table 107. Anti-Inflammatory Cytokine Market Drivers in Global Market
Table 108. Anti-Inflammatory Cytokine Market Restraints in Global Market
Table 109. Anti-Inflammatory Cytokine Raw Materials
Table 110. Anti-Inflammatory Cytokine Raw Materials Suppliers in Global Market
Table 111. Typical Anti-Inflammatory Cytokine Downstream
Table 112. Anti-Inflammatory Cytokine Downstream Clients in Global Market
Table 113. Anti-Inflammatory Cytokine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Inflammatory Cytokine Segment by Type in 2022
Figure 2. Anti-Inflammatory Cytokine Segment by Application in 2022
Figure 3. Global Anti-Inflammatory Cytokine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Inflammatory Cytokine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Inflammatory Cytokine Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Inflammatory Cytokine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Inflammatory Cytokine Revenue in 2022
Figure 9. By Type - Global Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Inflammatory Cytokine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Inflammatory Cytokine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Inflammatory Cytokine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 23. US Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 28. Germany Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 37. China Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Inflammatory Cytokine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Inflammatory Cytokine Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Inflammatory Cytokine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Inflammatory Cytokine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Inflammatory Cytokine by Region, 2022 VS 2029
Figure 54. Anti-Inflammatory Cytokine Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗炎症性サイトカインの世界市場見通し2023年-2029年(Anti-Inflammatory Cytokine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗炎症性サイトカインの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp